Neo-Adjuvant Oncolytic Virotherapy Prior to Surgery Sensitizes Triple-Negative Breast Cancer to Immune Checkpoint Therapy
Ontology highlight
ABSTRACT: Neo-Adjuvant Oncolytic Virotherapy Prior to Surgery Sensitizes Triple-Negative Breast Cancer to Immune Checkpoint Therapy
PROVIDER: PRJNA413701 | ENA |
REPOSITORIES: ENA
ACCESS DATA